Skip to main content

Table 5 Differentially expressed pathways in infants with BPD versus infants without BPD

From: Perturbation of gene expression of the chromatin remodeling pathway in premature newborns at risk for bronchopulmonary dysplasia

Gene set/pathway

NTk q value

NEk q value

Regulation of cell growth (GO:0001558)

0.0

0.0

Nuclear pore complex (GO:0046930)

0.0

0.03

Negative regulation of cellular metabolism (GO:0031324)

0.0

0.04

Chromatin remodeling (GO:0016568)

0.0

0.055

PI3K-AKT signaling pathway (humanpaths)

0.0

0.1

Histone acetyltransferase binding (GO:0035035)

0.0

0.2

cAMP/Ca2+ signaling (humanpaths)

0.0

0.3

Spliceosome complex (GO:0005681)

0.0

0.9

  1. Shown here are the pathways (with redundant pathways removed as well as those that overlapped with Table 4) that were ranked at the top of the list of those differentially expressed by two measures of false discovery: the NTk q value and the NEk q value. The NTk q value corresponds to the degree to which genes within a set/pathway are more predictive of the phenotype than the genes outside that set, and the NEk q value corresponds to the degree to which genes within that set are predictive of the phenotype. Only those pathways with an NTk q value below 10-4 and a NEk q value below 1 are shown above. Each pathway is annotated by ontology source (Gene Ontology [GO] or humanpaths). BPD, bronchopulmonary dysplasia; PI3K, phosphoinositide-3 kinase.